By
AmyT on
January 19, 2010
Last week, I spent a little bit of time at the JP Morgan Healthcare Conference, a nearly-thirty-year-old annual gathering that’s become “the health care industry’s premier financial event, giving more than 330 companies a chance to make formal pitches to institutional investors.” Due to a houseful of sickies at home, I wasn’t able to attend as many presentations as I’d have liked, but I did catch a few of the “biggies,” including the talk by…
Read more »
By
AmyT on
January 4, 2010
Over the holidays, hubby and I managed to slip away for one-night romantic getaway, and I finally did it! (Check your imaginations at the door, Guys – nothing kinky) I finally decided to enjoy a hot and steamy jacuzzi session without worrying about my OmniPod. Not where it was, or wasn’t, or what was happening to the fragile insulin inside.
This February will mark my three-year anniversary wearing the thing, and I love the freedom…
Read more »
By
AmyT on
November 24, 2009
In honor of both National Diabetes Month and the upcoming Thanksgiving holiday, I wanted to share with you the story of a man whom we all owe a debt of gratitude: Dr. Frederick Banting.
Some of you may know this, but World Diabetes Day was chosen to be on November 14 because it is Dr. Banting’s birthday. He was born on November 14, 1891, which meant this year he would have been 118 years old.…
Read more »
By
AmyT on
November 17, 2009
Al Mann, CEO of MannKind Corp., is something of a legend in his own time. He not only founded MiniMed, acquired by Medtronic, but also four other successful medical companies. He’s a billionaire, with his own Biomedical Engineering Institute at the University of Southern California (USC), so we can assume that he’s not just championing the new inhalable insulin product Technosphere (brand name Afresa) as some kind of pipe dream or get-rich-quick scheme.
The guy…
Read more »
By
AmyT on
November 13, 2009
Today, just a sampling of some of the interesting stuff presented at last week’s Diabetes Technology Society meeting, that will be out on the market in … um… some years from now (?):
IN-105 Oral Insulin for Type 2 diabetes – Biocon Limited, apparently India’s premier biotechnology company, has been developing oral insulin tablets for some years now. Positive research results were announced last year. And they’re not just for basal use, either. Studies confirmed…
Read more »
